http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015175997-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 |
| filingDate | 2015-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fa8d7d931625a75f29ab789f4882159 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c49d1702da595a9421e63b946a3de1b9 |
| publicationDate | 2015-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2015175997-A1 |
| titleOfInvention | Methods and pharmaceutical compositions for treating diseases associated with altered sert activity |
| abstract | The present invention provides, inter alia, methods for treating or ameliorating the effects of a disease associated with altered serotonin transporter molecule (SERT) activity in a subject in need thereof. The methods include administering to the subject an effective amount of a 5-HT 4 agonist or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions and kits for the same are also provided. The present invention additionally provides methods for treating or ameliorating the effects of elevated serotonin transporter molecule activity in the gastrointestinal tract of a subject in need thereof and a gastrointestinal abnormality associated with autism spectrum disorder in a subject in need thereof. |
| priorityDate | 2014-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.